Abstract
Whole breast external beam radiotherapy is a safe and effective treatment, but despite the advances that have been achieved over the years, there are a number of areas where further improvements might be made. First, there is an undesirable delivery of radiation to normal tissues such as the skin, heart, ribs and lungs. The radiotherapy is delivered as daily fractions spread over several weeks, which entails daily visits to the radiotherapy centre. There is a delay between surgery and radiotherapy, which can be several months if chemotherapy is given. Finally, there is a risk of “geographic miss” of the tumour bed, particularly if cosmetic reconstruction has been performed. The TARGIT technique directly addresses these concerns, as the radiotherapy is delivered from within the breast only to the tumour bed, under direct visualisation at the time of surgery, in a single fraction.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Belletti B, Vaidya JS, D’Andrea S, Entschladen F, Roncadin M, Lovat F et al (2008) Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding. Clin Cancer Res 14:1325–1332
TARGIT E on the ClinicalTrials.gov website. http://clinicaltrials.gov/ct2/show/NCT01299987
TARGIT US on the ClinicalTrials.gov website. http://clinicaltrials.gov/ct2/show/NCT01570998
Enderling H, Chaplain MA, Anderson AR, Vaidya JS (2007) A mathematical model of breast cancer development, local treatment and recurrence. J Theor Biol 246:245–259
TARGIT B Trial on the HTA website. http://www.hta.ac.uk/2946
TARGIT A Trial on the HTA website. http://www.hta.ac.uk/project/1981
Polgár C, Van Limbergen E, Pötter R, Kovács G, Polo A, Lyczek J et al (2010) Patient selection for accelerated partial breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groups Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) Breast Cancer Working Group based on clinical evidence (2009). Radiother Oncol 94:264–273
Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hahn CA, Hardenburgh PH et al (2009) Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 74:987–1001
Vaidya JS, Joseph DJ, Tobias JS, Bulsara M, Wenz F, Saunders C et al (2010) Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 376:91–102
Vaidya JS, Baum M, Tobias JS, Wenz F, Massarut S, Keshtgar M et al (2011) Long-term results of targeted intraoperative radiotherapy (Targit) boost during breast-conserving surgery. Int J Radiat Oncol Biol Phys 81:1091–1097
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Williams, N.R., Reynolds, C. (2014). Treating Patients with TARGIT. In: Keshtgar, M., Pigott, K., Wenz, F. (eds) Targeted Intraoperative Radiotherapy in Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39821-6_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-39821-6_17
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-39820-9
Online ISBN: 978-3-642-39821-6
eBook Packages: MedicineMedicine (R0)